Pharmacogenomics is Estimated to Witness High Growth Owing to Rising Demand for Personalized MedicinePharmacogenomics is the study of how genes affect an individual's response to drugs. It develops and applies mapping information on how genes influence individual variations in drug responses such as drug efficacy and toxicity. Pharmacogenomics provides an opportunity for healthcare...
The pharmacogenomics market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is estimated to grow at a CAGR of 10.3% from 2021 to 2028.
The Global pharmacogenomics market was recently published by Thinking Caps Research & Consultancy, which includes the growth rate, analysis by product type, application analysis, end-user analysis, market...
Pharmacogenomics Market Summary
The global Pharmacogenomics market study and trends analysis by product type, applications, and end-user classification offer an in-depth study of the Pharmacogenomics market segment. Straits Research being in the market research industry for a long time now has earned the reputation of being one of the most trusted and genuine market research and Intelligence...
The Pharmacogenomics Market in 2023 is US$ 15.61 billion, and is expected to reach US$ 36.8 billion by 2031 at a CAGR of 11.30%.
FutureWise Research published a report that analyzes Pharmacogenomics Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends...
The global Pharmacogenomics Market is expected to reach USD 11.97 Billion by 2027, according to a new report by Emergen Research. The global pharmacogenomics (PGx) market is growing at a substantial pace owing to the growing demand for personalized therapy, increasing prevalence of target chronic diseases, technological advancements, favorable government initiatives, availability of financial...